Posted by Michael Wonder on 28 Oct 2016
Post-market review of ezetimibe – targeted stakeholder forum
28 October 2016 - The Reference Group of the Post-market Review of ezetimibe has requested that a targeted Stakeholder Forum be held in Canberra on Friday 11 November 2016 to seek additional stakeholder input to further inform the Review.
The forum will be specifically targeted to pharmaceutical sponsors who either have a current PBS medicine listing for ezetimibe or in combination with ezetimibe, or propose to have one in the near future.
Stakeholders who wish to attend and have not received an invitation should submit an expression of interest to the Ezetimibe Review Secretariat by COB Friday 4 November 2016.
